164 related articles for article (PubMed ID: 34985017)
1. Interleukins in the treatment of melanoma.
Xu X; Dai W; Li C
Chin Med J (Engl); 2022 Jan; 135(4):393-399. PubMed ID: 34985017
[TBL] [Abstract][Full Text] [Related]
2. Interleukins in cancer: from biology to therapy.
Briukhovetska D; Dörr J; Endres S; Libby P; Dinarello CA; Kobold S
Nat Rev Cancer; 2021 Aug; 21(8):481-499. PubMed ID: 34083781
[TBL] [Abstract][Full Text] [Related]
3. Cytokines in the Treatment of Melanoma.
Bentebibel SE; Diab A
Curr Oncol Rep; 2021 May; 23(7):83. PubMed ID: 34003395
[TBL] [Abstract][Full Text] [Related]
4. Interleukins (ILs), a fascinating family of cytokines. Part II: ILs from IL-20 to IL-38.
Fietta P; Costa E; Delsante G
Theor Biol Forum; 2015; 108(1-2):19-40. PubMed ID: 27167908
[TBL] [Abstract][Full Text] [Related]
5. Interleukins (ILs), a fascinating family of cytokines. Part I: ILs from IL-1 to IL-19.
Fietta P; Costa E; Delsante G
Theor Biol Forum; 2014; 107(1-2):13-45. PubMed ID: 25936211
[TBL] [Abstract][Full Text] [Related]
6. Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases.
Zhao Y; Wang H; Jin L; Zhang Z; Liu L; Zhou M; Zhang X; Zhang L
Eur J Pharm Sci; 2024 Jan; 192():106647. PubMed ID: 37984595
[TBL] [Abstract][Full Text] [Related]
7. Antitumor Activities of Interleukin-12 in Melanoma.
Gao W; Pan J; Pan J
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428682
[TBL] [Abstract][Full Text] [Related]
8. The use of interleukins for advanced melanoma.
Miller SJ
Skin Therapy Lett; 2001; 6(4):3-5. PubMed ID: 11176044
[TBL] [Abstract][Full Text] [Related]
9. Modulating Interleukins and their Receptors Interactions with Small Chemicals Using In Silico Approach for Asthma.
Majumdar S; Ghosh A; Saha S
Curr Top Med Chem; 2018; 18(13):1123-1134. PubMed ID: 30068279
[TBL] [Abstract][Full Text] [Related]
10. The potential role of interleukins and interferons in ovarian cancer.
Huldani H; Abdul-Jabbar Ali S; Al-Dolaimy F; Hjazi A; Denis Andreevich N; Oudaha KH; Almulla AF; Alsaalamy A; Kareem Oudah S; Mustafa YF
Cytokine; 2023 Nov; 171():156379. PubMed ID: 37757536
[TBL] [Abstract][Full Text] [Related]
11. ILs-3, 6 and 11 increase, but ILs-10 and 24 decrease stemness of human prostate cancer cells in vitro.
Yu D; Zhong Y; Li X; Li Y; Li X; Cao J; Fan H; Yuan Y; Ji Z; Qiao B; Wen JG; Zhang M; Kvalheim G; Nesland JM; Suo Z
Oncotarget; 2015 Dec; 6(40):42687-703. PubMed ID: 26528857
[TBL] [Abstract][Full Text] [Related]
12. Interleukins and Ischemic Stroke.
Zhu H; Hu S; Li Y; Sun Y; Xiong X; Hu X; Chen J; Qiu S
Front Immunol; 2022; 13():828447. PubMed ID: 35173738
[TBL] [Abstract][Full Text] [Related]
13. Evolutionary divergence and functions of the human interleukin (IL) gene family.
Brocker C; Thompson D; Matsumoto A; Nebert DW; Vasiliou V
Hum Genomics; 2010 Oct; 5(1):30-55. PubMed ID: 21106488
[TBL] [Abstract][Full Text] [Related]
14. IL-32γ potentiates tumor immunity in melanoma.
Gruber T; Kremenovic M; Sadozai H; Rombini N; Baeriswyl L; Maibach F; Modlin RL; Gilliet M; von Werdt D; Hunger RE; Seyed Jafari SM; Parisi G; Abril-Rodriguez G; Ribas A; Schenk M
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32841222
[TBL] [Abstract][Full Text] [Related]
15. Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases.
Akdis M; Burgler S; Crameri R; Eiwegger T; Fujita H; Gomez E; Klunker S; Meyer N; O'Mahony L; Palomares O; Rhyner C; Ouaked N; Schaffartzik A; Van De Veen W; Zeller S; Zimmermann M; Akdis CA
J Allergy Clin Immunol; 2011 Mar; 127(3):701-21.e1-70. PubMed ID: 21377040
[TBL] [Abstract][Full Text] [Related]
16. Targeting interleukins for the treatment of inflammatory bowel disease-what lies beyond anti-TNF therapy?
McLean MH; Neurath MF; Durum SK
Inflamm Bowel Dis; 2014 Feb; 20(2):389-97. PubMed ID: 24356385
[TBL] [Abstract][Full Text] [Related]
17. IL-24 gene transfer sensitizes melanoma cells to erlotinib through modulation of the Apaf-1 and Akt signaling pathways.
Deng WG; Kwon J; Ekmekcioglu S; Poindexter NJ; Grimm EA
Melanoma Res; 2011 Feb; 21(1):44-56. PubMed ID: 20216471
[TBL] [Abstract][Full Text] [Related]
18. Interrelationship between inflammatory cytokines (IL-1, IL-6, IL-33, IL-37) and acquired immunity.
Franza L; Carusi V; Altamura S; Caraffa A; Gallenga CE; Kritas SK; Ronconi G; Conti P; Pandolfi F
J Biol Regul Homeost Agents; 2019; 33(5):1321-1326. PubMed ID: 31663301
[TBL] [Abstract][Full Text] [Related]
19. Predictive Value of Serum Interleukins in Children with Idiopathic Nephrotic Syndrome.
Nickavar A; Valavi E; Safaeian B; Amoori P; Moosavian M
Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):632-639. PubMed ID: 33463132
[TBL] [Abstract][Full Text] [Related]
20. Maximum-likelihood approaches reveal signatures of positive selection in IL genes in mammals.
Neves F; Abrantes J; Steinke JW; Esteves PJ
Innate Immun; 2014 Feb; 20(2):184-91. PubMed ID: 23775092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
